Myklebust A T, Helseth A, Breistøl K, Hall W A, Fodstad O
Department of Tumor Biology, Norwegian Radium Hospital, Oslo.
J Neurooncol. 1994;21(3):215-24. doi: 10.1007/BF01063770.
Models for hematogenous spread of human cancer to the central nervous system (CNS) were established by injecting human tumor cells into the internal carotid artery of nude rats. With 4 out of 10 cell lines, belonging to four different tumor types, metastases developed in all injected animals. Tumor growth manifested clinically as neurological symptoms which appeared after a median latency ranging from 19-87 days for the different tumors. The H-146 and DMS-273 small cell lung cancers and the LOX melanoma almost exclusively gave meningeal tumors, whereas with FEMX-I melanoma cells bone metastases in the skull dominated. For these tumor types a correlation was found between the capacity for experimental metastasis formation and the s.c. tumorigenicity. In agreement with clinical experience, none of the 2 sarcoma and 2 glioblastoma lines gave CNS metastases. With a modified microsurgical technique, allowing for repeated ipsilateral intracarotid injections, we analyzed the drug concentrations obtained in tumor and surrounding brain tissue after i.v. treatment with doxorubicin. The concentration in the LOX tumor reached therapeutic levels and was approximately 100 x higher than in normal brain tissue, both with and without intraarterial pretreatment with arabinose. In the same model, the tissue concentrations of 9.2.27-abrin immunotoxin 10 min after intracarotid injection were examined. Although the levels were low, a tumor to brain concentration ratio of up to 9 was achieved. The data demonstrate that clinically relevant tumor models can be established with the techniques described, and these models may successfully be used to evaluate the pharmacokinetics and effect of intravenous or intraarterial therapy.
通过将人类肿瘤细胞注入裸鼠的颈内动脉,建立了人类癌症血行播散至中枢神经系统(CNS)的模型。在10种细胞系中,有4种属于4种不同的肿瘤类型,所有注射动物均发生了转移。肿瘤生长在临床上表现为神经症状,不同肿瘤出现症状的中位潜伏期为19 - 87天。H - 146和DMS - 273小细胞肺癌以及LOX黑色素瘤几乎只产生脑膜肿瘤,而FEMX - I黑色素瘤细胞则以颅骨骨转移为主。对于这些肿瘤类型,发现实验性转移形成能力与皮下致瘤性之间存在相关性。与临床经验一致,2种肉瘤和2种胶质母细胞瘤细胞系均未发生CNS转移。采用改良的显微外科技术,允许重复同侧颈内动脉注射,我们分析了静脉注射阿霉素后肿瘤及周围脑组织中的药物浓度。无论有无用阿拉伯糖进行动脉内预处理,LOX肿瘤中的浓度均达到治疗水平,且比正常脑组织中的浓度高约100倍。在同一模型中,检测了颈内动脉注射后10分钟9.2.27 -相思子毒素免疫毒素的组织浓度。尽管浓度较低,但肿瘤与脑的浓度比高达9。数据表明,利用所述技术可以建立与临床相关的肿瘤模型,这些模型可成功用于评估静脉或动脉内治疗的药代动力学和效果。